JENNIFER SCHAFBUCH: Open Payments
NPI 1295460848 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 11 payments from 8 companies in 2025. Trend: 2023 $416 · 2024 $235 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $38 |
| ABBVIE INC. | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Exact Sciences Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Cologuard Collection Kit, MOUNJARO, Wegovy, GVOKE HYPOPEN, NEFFY, QULIPTA, REXULTI, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
